These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28356022)

  • 21. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
    Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
    Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schiff Bases and their Metal Complexes as Potential Anticancer Candidates: A Review of Recent Works.
    Tadele KT; Tsega TW
    Anticancer Agents Med Chem; 2019; 19(15):1786-1795. PubMed ID: 30827264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indolylmethylene benzo[h]thiazolo[2,3-b]quinazolinones: synthesis, characterization and evaluation of anticancer and antimicrobial activities.
    Gali R; Banothu J; Porika M; Velpula R; Hnamte S; Bavantula R; Abbagani S; Busi S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4239-42. PubMed ID: 25096298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents.
    Alam MS; Nam YJ; Lee DU
    Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Tetrahydrobenzo [b] Thiophene Compounds Exhibit Anticancer Activity through Enhancing Apoptosis and Inhibiting Tyrosine Kinase.
    El-Metwally SA; Khalil AK; El-Naggar AM; El-Sayed WM
    Anticancer Agents Med Chem; 2018; 18(12):1761-1769. PubMed ID: 30101717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 4-aminoquinazoline derivatives as new leads for anticancer drug discovery.
    Ghorab MM; Alsaid MS
    Acta Pharm; 2015 Sep; 65(3):299-309. PubMed ID: 26431107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
    Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
    Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
    Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
    ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis and Anticancer Evaluation of Novel Quinazoline-Sulfonamide Hybrids.
    Ghorab MM; Alsaid MS; Al-Dosari MS; El-Gazzar MG; Parvez MK
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26861266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors.
    Ghorab MM; Alsaid MS; Nissan YM; Ashour AE; Al-Mishari AA; Kumar A; Ahmed SF
    Chem Pharm Bull (Tokyo); 2016; 64(12):1747-1754. PubMed ID: 27904083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity.
    Xu YY; Li SN; Yu GJ; Hu QH; Li HQ
    Bioorg Med Chem; 2013 Oct; 21(19):6084-91. PubMed ID: 23962660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
    Yurttaş L; Çiftçi GA
    Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual EGFR/HER2 inhibitors and apoptosis inducers: New benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers.
    Ghorab MM; Alsaid MS; Soliman AM
    Bioorg Chem; 2018 Oct; 80():611-620. PubMed ID: 30041137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
    Luo H; Yang S; Cai Y; Peng Z; Liu T
    Eur J Med Chem; 2014 Sep; 84():746-52. PubMed ID: 25064351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some new nano-sized Fe(II), Cd(II) and Zn(II) Schiff base complexes as precursor for metal oxides: Sonochemical synthesis, characterization, DNA interaction, in vitro antimicrobial and anticancer activities.
    Abdel-Rahman LH; Abu-Dief AM; El-Khatib RM; Abdel-Fatah SM
    Bioorg Chem; 2016 Dec; 69():140-152. PubMed ID: 27816797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, molecular docking and antitumor activity of novel pyrrolizines with potential as EGFR-TK inhibitors.
    Belal A
    Bioorg Chem; 2015 Apr; 59():124-9. PubMed ID: 25748126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
    Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
    Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 4-arylaminoquinazoline derivatives with (E)-propen-1-yl moiety as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells.
    Chen L; Zhang Y; Liu J; Wang W; Li X; Zhao L; Wang W; Li B
    Eur J Med Chem; 2017 Sep; 138():689-697. PubMed ID: 28711703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors.
    Makawana JA; Sangani CB; Lin L; Zhu HL
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1734-6. PubMed ID: 24630412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.